Study to Assess Acute Vasodilation Response of Inhaled Nitric Oxide
Status:
Withdrawn
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The EAGLE study is a Phase 3, open-label, multi-center, two-part, single-arm study of
GeNOsyl(R) delivery system(s) to evaluate if inhaled nitric oxide-induced vasodilation
predicts successful wean from parenteral prostacyclin (PGI) in subjects with World Health
Organization (WHO) Group 1 pulmonary arterial hypertension (PAH) undergoing a medically
necessary right heart catheterization (RHC). All subjects enrolled in the study will undergo
an attempt to wean from parenteral PGI per standard of care.